APOE and Alzheimer disease: The potential mechanism by which this genotype contributes to the risk for the development of AD could be mediated by a decrease in sRAGE, however, the results of the case-control analysis in the EOAD/LOAD or ApoE subgroups remain preliminary due to the small number of subjects, and further studies with a larger cohort in different populations are required.